$626.59 0.9%
MCK Stock Price vs. AI Score
Data gathered: November 21

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - McKesson (MCK)

Analysis generated September 27, 2024. Powered by Chat GPT.

McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology, specialty care, and healthcare information technology. The company distributes pharmaceuticals at a national network of distribution centers and provides healthcare management tools and scalable solutions to reduce costs, improve operational efficiency and enhance the quality of care. With a robust history of innovation and leadership, McKesson plays a pivotal role in the healthcare industry.

Read full AI stock Analysis

Stock Alerts - McKesson (MCK)

company logo McKesson | November 8
AI Score is up by 24.5% in the last couple of days.
company logo McKesson | November 8
Byron Donalds (member of U.S. congress) is buying shares
company logo McKesson | November 7
Price is up by 8.6% in the last 24h.
company logo McKesson | November 1
Price is up by 5.1% in the last 24h.

About McKesson

Incorporated in 1833, Texas-based McKesson Corp. provides pharmaceuticals, health information technology, medical supplies, and care management tools. The company operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions.


McKesson
Price $626.59
Target Price Sign up
Volume 59,270
Market Cap $78.2B
Year Range $479.06 - $629.58
Dividend Yield 0.46%
PE Ratio 31.85
Analyst Rating 87% buy
Industry Digital health

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '2493.7B93.2B3.25B241M626M7.070
Q2 '2479.3B78.2B3.15B915M1.18B7.880
Q1 '2476.3B75.4B3.59B791M1.66B6.180
Q4 '2380.8B80.3B3.15B589M697M7.740
Q3 '2377.2B76.3B3.07B664M1B6.230

Insider Transactions View All

TYLER BRIAN S. filed to sell 78,586 shares at $561.1.
September 6 '24
TYLER BRIAN S. filed to sell 82,339 shares at $626.
August 6 '24
TYLER BRIAN S. filed to sell 86,092 shares at $580.9.
July 8 '24
Smith LeAnn B filed to sell 2,022 shares at $585.5.
June 12 '24

What is the Market Cap of McKesson?

The Market Cap of McKesson is $78.2B.

What is McKesson's PE Ratio?

As of today, McKesson's PE (Price to Earnings) ratio is 31.85.

What is the current stock price of McKesson?

Currently, the price of one share of McKesson stock is $626.59.

How can I analyze the MCK stock price chart for investment decisions?

The MCK stock price chart above provides a comprehensive visual representation of McKesson's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling McKesson shares. Our platform offers an up-to-date MCK stock price chart, along with technical data analysis and alternative data insights.

Does MCK offer dividends to its shareholders?

Yes, McKesson (MCK) offers dividends to its shareholders, with a dividend yield of 0.46%. This dividend yield represents McKesson's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering McKesson in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of McKesson?

Some of the similar stocks of McKesson are Teladoc Health, Veeva Systems, Doximity, GoodRx, and Lifestance Health.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.